DOCSLIB.ORG

Aldrich FT-IR Collection Edition I Supplement

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Aldrich FT-IR Collection Edition I Supplement Aldrich FT-IR Collection Edition I Supplement Library Listing – 7,949 spectra This library is a collection of spectra not found in the original Aldrich Collection of FT-IR Spectra Edition I. Combining this collection with the Edition I collection provides the same chemical compound coverage as the Aldrich Collection of FT- IR Spectra Edition II. The Aldrich Collection of FT-IR Spectra Edition I Supplement covers a wide variety of functional groups and was acquired using the same standards and procedures as the original library. This collection includes 7,949 spectra and comes with the Second Edition of the Aldrich Library of FT-IR spectra reference books. Aldrich FT-IR Collection Edition I Supplement Index Compound Name Index Compound Name 976 ((1S)-ENDO)-(-)-3- 4014 (+)-6-METHOXY-ALPHA- BROMOCAMPHOR, 98% METHYL-2- 2816 ((4-(1-HEPTYL-8-(3- NAPHTHALENEACETIC ACID, (OXIRANYLMETHOXY)PHENYL 98% )OCTYL) 7238 (+)-B- PHENOXY)METHYL)OXIR METHOXYDIISOPINOCAMPHEY 7537 ((R)-(+)-2,2'- LBORANE BIS(DIPHENYLPHOSPHINO)- 99 (+)-BETA-PINENE, 98% 1,1'-BINAPH)(1,5- 4524 (+)-BICUCULLINE, 98% CYCLOOCTADIENE) 3435 (+)-BOLDINE 7539 ((R)-(+)-2,2'- HYDROCHLORIDE, 99% BIS(DIPHENYLPHOSPHINO)- 282 (+)-BORNEOL, 98% 1,1'- 1182 (+)-CAMPHORCARBOXYLIC BINAPHTHYL)PALLADIUM(II) ACID, 98%, MIXTURE OF ENDO CH AND EXO 5306 ((R)-(+)-3-HYDROXY-2- 410 (+)-CHLOROMETHYL METHYLPROPYL)- TRIPHENYL- MENTHYL ETHER, 97% PHOSPHONIUM BROMIDE, 9 275 (+)-CIS-P-MENTHANE-3,8-DIOL, 7538 ((S)-(-)-2,2'- 97% BIS(DIPHENYLPHOSPHINO)- 4441 (+)-COREY LACTONE, 4- 1,1'-BINAPH)(1,5- PHENYLBENZOATE ALCOHOL, CYCLOOCTADIENE) 99% 5307 ((S)-(-)-3-HYDROXY-2- 79 (+)-CYCLOSATIVENE, 99% METHYLPROPYL)- TRIPHENYL- 7501 (+)-DI-MU-CHLOROBIS(2-(1- PHOSPHONIUM BROMIDE, 9 (DIMETHYLAMINO)ETHYL)PHE 2805 ((TETRAMETHYL-1,4- NYL-C,N)DIPALLADIUM, PHENYLENE)DIMETHYLENE)BI 4316 (+)-DIMETHYL 2,3-O- S(TERT-BUTYL PEROXIDE) BENZYLIDENE-D- TARTRATE, 1204 (+)-(18-CROWN-6)-2,3,11,12- 99% TETRACARBOXYLICACID 1806 (+)-DIMETHYL 2,3-O- 3024 (+)-(4,6-O- ISOPROPYLIDENE-D BENZYLIDENE)METHYL- TARTRATE, 98% ALPHA-D- 6717 (+)-EQUILENIN, 98% GLUCOPYRANOSIDE, 97% 290 (+)-ISOPULEGOL, 99% 4942 (+)-(4S)-PHENYL-A-((4S)- 1155 (+)-MENTHOXYACETIC ACID, PHENYLOXAZOLIDIN-2- 98% YLIDEN)-2-OXAZOLIN-2-ACETO 5252 (+)- 7585 (+)-(S)-1-((R)-2- NEOMENTHYLDIPHENYLPHOS (DIPHENYLPHOSPHINO)FERRO PHINE, TECH. 85% CENYL)ETHYL METHYL 2014 (+)-PANTOTHENIC ACID, ETHER, 98 SODIUM SALT, 95% 7591 (+)-(S)-N,N-DIMETHYL-1-((R)- 6346 (+)-TAPA, 97% 1',2-BIS(DI- 3442 (+)-TETRAHYDROPALMATINE PHENYLPHOSPHINO)FERROCE HYDROCHLORIDE, 95% NYL)E 3765 (+)-USNIC ACID, 98% 7587 (+)-(S)-N,N-DIMETHYL-1-((R)-2- 6807 (+)METHAMPHETAMINE (DIPHENYLPHOSPHINO)FERRO HYDROCHLORIDE CENYL)ETHYLAMIN 5435 (+/-)-2-(EPOXYETHYL)FURAN, 2443 (+)-10- 97% DICYCLOHEXYLSULFAMOYL- 3726 (+/-)-2- L- ISOBORNEOL, 98% (METHYLAMINO)PROPIOPHEN 3023 (+)-2,3-O-BENZYLIDENE-D- ONE HYDROCHLORIDE, 99% THREITOL, 99% 4520 (+/-)-3-BENZYLPHTHALIDE, 98% 7099 (+)-3',5'-O-(1,1,3,3- 2990 (+/-)-4-FLUORO-ALPHA-(N- TETRAISOPROPYL-1,3- PROPYL)-BENZYL ALCOHOL DISILOXANEDIYL)CYTIDINE, 4514 (+/-)-ALPHA-CARBETHOXY- 97% GAMMA-PHENYL- GAMMA- BUTYROLACTONE, 95% 2216 (+/-)-CYTISINE, 97% (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 1 of 146 Aldrich FT-IR Collection Edition I Supplement Index Compound Name Index Compound Name 524 (+/-)-GLYCIDYL METHYL 1183 (-)-CAMPHORCARBOXYLIC ETHER, 99% ACID, 98%, MIXTURE OF ENDO 2988 (+/-)-METHYL-ALPHA- AND EXO PROPYLBENZYL ALCOHOL, 409 (-)-CHLOROMETHYL MENTHYL 98% ETHER, 97% 3342 (+/-)-N- 5947 (-)-COTININE, 98% ETHYLNORPHENYLEPHRINE 2217 (-)-CYTISINE, 98% HYDROCHLORIDE, 98% 1566 (-)-DIMENTHYL FUMARATE, 3369 (+/-)-NOREPINEPHRINE L- 95% BITARTRATE HYDRATE, 99% 4317 (-)-DIMETHYL 2,3-O- 2476 (+/-)-TRANS,1,2- BENZYLIDENE-L- TARTRATE, BIS(DICHLOROPHOSPHINO)- 99% CYCLOPENTANE, TECH., 90% 1805 (-)-DIMETHYL 2,3-O- 293 (+/-)-TRANS-2-CYCLOHEXENE- ISOPROPYLIDENE-L 1,4-DIOL, 98% TARTRATE, 97% 2994 (+/-)ALPHA-CYCLOPROPYL- 7236 (-)-DIP-CHLORIDE ALPHA,4-DIMETHYL- BENZYL 286 (-)-GUAIOL, 97% ALCOHOL 102 (-)-ISOCARYOPHYLLENE, 98% 3055 (-)-(4,6-O- 3373 (-)-ISOPROTERENOL BENZYLIDENE)PHENYL-BETA- HYDROCHLORIDE D- GLUCOPYRANOSIDE 291 (-)-ISOPULEGOL, 99% 7584 (-)-(R)-1-((S)-2- 6774 (-)-ISORESERPINE, 95% (DIPHENYLPHOSPHINO)FERRO 3458 (-)-N-BENZYL-N- CENYL)ETHYL METHYL METHYLEPHEDRINIUM ETHER, 98 BROMIDE, 99% 7590 (-)-(R)-N,N-DIMETHYL-1-((S)- 6719 (-)-NORGESTREL, 98% 1',2-BIS(DIPHENYL- 299 (-)-QUEBRACHITOL, 97% PHOSPHINO)FERROCENYL)ET 6347 (-)-TAPA, 97% 7586 (-)-(R)-N,N-DIMETHYL-1-((S)-2- 3443 (-)-TETRAHYDROPALMATINE (DIPHENYLPHOSPHINO)FERRO HYDROCHLORIDE, 85% CENYL)ETHYLAMIN 973 (-)-THUJONE 2442 (-)-10- 276 (-)-TRANS-P-MENTHANE-3,8- DICYCLOHEXYLSULFAMOYL- DIOL, 97% D- ISOBORNEOL, 98% 7526 (1,2- 5158 (-)-2,3-BUTANEDIOL DI-P- BIS(DIPHENYLPHOSPHINO)ETH TOSYLATE, 99% ANE)DICHLOROCOBALT(II) 2201 (-)-2-OXO-4- 7525 (1,2- THIAZOLIDINECARBOXYLIC BIS(DIPHENYLPHOSPHINO)ETH ACID, 97% ANE)DICHLOROIRON(II), 96% 7100 (-)-3',5'-O-(1,1,3,3- 7527 (1,2- TETRAISOPROPYL-1,3- BIS(DIPHENYLPHOSPHINO)ETH DISILOXANEDIYL)ADENOSINE, ANE)DICHLORONICKEL(II) 97 7528 (1,2- 3374 (-)-3,4- BIS(DIPHENYLPHOSPHINO)ETH DIHYDROXYNOREPHEDRINE, ANE)DICHLOROPALLADIUM(II) 98% , 98% 1022 (-)-3- 7625 (1,2- (TRIFLUOROACETYL)CAMPHO BIS(DIPHENYLPHOSPHINO)ETH R, 98% ANE)TUNGSTEN 3046 (-)-8-PHENYLMENTHOL, 98% TETRACARBONYL, 97% 95 (-)-ALPHA-CUBEBENE, 97% 7533 (1,3- 3334 (-)-ALPRENOLOL L-TARTRATE BIS(DIPHENYLPHOSPHINO)PRO HYDRATE, 98% PANE)DICHLORONICKEL(II) 2836 (-)-ASARININ, 97% 7222 (1,3-DIOXAN-2- 7239 (-)-B- YLETHYNYL)TRIMETHYLSILA METHOXYDIISOPINOCAMPHEY NE, 96% LBORANE 4522 (-)-BETA-NARCOTINE 4525 (-)-BICUCULLINE METHIODIDE, 98% (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 2 of 146 Aldrich FT-IR Collection Edition I Supplement Index Compound Name Index Compound Name 7534 (1,4- 982 (1R)-(-)-THIOCAMPHOR, 97% BIS(DIPHENYLPHOSPHINO)BUT 729 (1R,2R)-(+)-1,2- ANE)(1,5- DIAMINOCYCLOHEXANE L- CYCLOOCTADIENE)RHODIUM(I TARTRATE, 99% ) TET 727 (1R,2R)-(-)-1,2- 7451 (1,5-CYCLOOCTADIENE)(2,4- DIAMINOCYCLOHEXANE, 98% PENTANEDIONATO)RHODIUM(I 262 (1R,2R)-(-)-1,2-DICYCLOHEXYL- ), 99% 1,2- ETHANEDIOL, 95% 7509 (1,5- 3305 (1R,2R)-(-)-PSEUDOEPHEDRINE, CYCLOOCTADIENE)BIS(METHY 98% LDIPHENYLPHOSPHINE)IRIDIU 732 (1R,2R)-N,N'-BIS(3,3- M(I) PF6, 97% DIMETHYLBUTYL)- 1,2- 7521 (1,5- CYCLOHEXANEDIAMINE, 97% CYCLOOCTADIENE)BIS(TRIPHE 269 (1R,2R)-TRANS-1,2- NYLPHOSPHINE)RHODIUM(I) CYCLOHEXANEDIOL, 99% HEXAFLUOROPHOSP 740 (1R,2R,3R,5S)-(-)- 7412 (1,5- ISOPINOCAMPHEYLAMINE, CYCLOOCTADIENE)DIIODOPLA 98% TINUM(II), 99.9% 5235 (1R,2R,3S)-(-)-3-(N- 7409 (1,5- BENZENESULFONYL-N-(3,5- CYCLOOCTADIENE)DIMETHYL DIMETHYLPHENYL)AMINO)-2- PLATINUM(II), 98% BO 6994 (1- 283 (1R,2R,3S,5R)-(-)-PINANEDIOL, BROMOVINYL)TRIMETHYLSIL 99% ANE, 97% 975 (1R,2R,5R)-(+)-2-HYDROXY-3- 7037 (1- PINANONE, 99% HYDROXYALLYL)TRIMETHYL 3380 (1R,2S)-(+)-CIS-1-AMINO-2- SILANE, 97% INDANOL, 99% 7076 (1-METHOXY-2- 3295 (1R,2S)-(-)-2-AMINO-1,2- (TRIMETHYLSILYL)VINYLOXY) DIPHENYLETHANOL, 99% TRIMETHYLSILANE, 98%, MIX 3302 (1R,2S)-(-)-NOREPHEDRINE, 99% OF IS 5234 (1R,2S,3R)-(+)-3-(N- 3971 (1A,2A,3B,4B)-2,4-BIS(4- BENZENESULFONYL-N-(3,5- HYDROXYPHENYL)- 1,3- DIMETHYLPHENYL)AMINO)-2- CYCLO- BO BUTANEDICARBOXYLIC 4254 (1R,2S,5R)-(+)-5-METHYL-2-(1- 2445 (1R)-(+)-2,10- METHYL-1- CAMPHORSULTAM, 98% PHENYLETHYL)CYCLOHEXYL 1918 (1R)-(+)-CAMPHANIC ACID, 98% CHLOROA 1970 (1R)-(+)-CAMPHANIC 1727 (1R,3S)-(+)-CIS-4- CHLORIDE, FLUKABRAND CYCLOPENTENE-1,3-DIOL 1- CHIRASELECT REAGENT, 97% ACETATE, 99+% 5238 (1R)-(+)-CAMPHOR P- 1169 (1R-(1A,2B,3A))-(+)-3-ME-2- TOSYLHYDRAZONE (NITROMETHYL)- 5- 974 (1R)-(+)-NOPINONE, 98% OXOCYCLOPENTANEACETIC 2449 (1R)-(-)-(10- ACI CAMPHORSULFONYL)OXAZIRI 1181 (1R-(2-ENDO,3-EXO))-3- DINE HYDROXY-4,7,7-TRIMETHYL- 2450 (1R)-(-)-(8,8-DICHLORO-10- BICYCLO(2.2.1)HEPTANE- CAMPHORSULFONYL)OXAZIRI 1189 (1R-TRANS)-2- DINE, 96% (BROMOMETHYL)-2-METHYL- 2437 (1R)-(-)-10- 3- CAMPHORSULFONYL METHYLENECYCLOPENTANEA CHLORIDE, 97% CETIC AC 1471 (1R)-(-)-DIMENTHYL 2448 (1S)-(+)-(10- SUCCINATE, 99% CAMPHORSULFONYL)OXAZIRI 1458 (1R)-(-)-MENTHYL ACETATE, DINE 98% 2036 (1S)-(+)-2- 1461 (1R)-(-)-NEOMENTHYL AZABICYCLO(2.2.1)HEPT-5-EN- ACETATE, 99% 3- ONE, 98+% (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 3 of 146 Aldrich FT-IR Collection Edition I Supplement Index Compound Name Index Compound Name 93 (1S)-(+)-3-CARENE, 99% 2809 (2,3-EPOXYPROPYL)BENZENE, 1021 (1S)-(+)-CAMPHORQUINONE, 98% 99% 3997 (2,4-DI-TERT- 1472 (1S)-(+)-DIMENTHYL PENTYLPHENOXY)ACETIC SUCCINATE, 99% ACID, 98% 1194 (1S)-(+)-KETOPINIC ACID, 99% 3618 (2,4- 1459 (1S)-(+)-MENTHYL ACETATE, DIMETHOXYPHENYL)ACETON 99% E, 98% 1460 (1S)-(+)-NEOMENTHYL 3996 (2,5- ACETATE, 99% DIMETHYLPHENOXY)ACETIC 2444 (1S)-(-)-2,10-CAMPHORSULTAM, ACID 98% 3282 (2,6-DICHLORO-4- 1919 (1S)-(-)-CAMPHANIC ACID, 99% (TRIFLUOROMETHYL)PHENYL) 5239 (1S)-(-)-CAMPHOR P- - HYDRAZINE, 98% TOSYLHYDRAZONE 5309 (2-(1,3-DIOXOLAN-2- 3294 (1S,2R)-(+)-2-AMINO-1,2- YL)ETHYL)TRIPHENYLPHOSPH DIPHENYLETHANOL, 99% ONIUM BROMIDE, 97% 3307 (1S,2R)-(+)-N- 3459 (2-(3,4-DICHLOROPHENYL)-2- METHYLEPHEDRINE, 99% HYDROXYETHYL)DIMETHYLIS 3303 (1S,2R)-(+)-NOREPHEDRINE, OPROPYLAMMONIUM IODI 98% 3504 (2-(4- 3379 (1S,2R)-(-)-CIS-1-AMINO-2- NITROPHENYL)ALLYL)TRIMET INDANOL, 99% HYLAMMONIUM IODIDE, 95% 726 (1S,2S)-(+)-1,2- 4349 (2-(ACRYLOYLOXY)ETHYL)(4- DIAMINOCYCLOHEXANE, 98% BENZOYLBENZYL)- (97% EE/GLC) DIMETHYLAMMONIUM 3316 (1S,2S)-(+)-2-AMINO-3- BROMIDE, 99 METHOXY-1-PHENYL-1- 1774 (2- PROPANOL, 98% (ACRYLOYLOXY)ETHYL)TRIM 3306 (1S,2S)-(+)-N- ETHYLAMMONIUM METHYL METHYLPSEUDOEPHEDRINE, SULFATE, 80 WT. % SOLN 99% 7209 (2- 3304 (1S,2S)-(+)-PSEUDOEPHEDRINE, (TRIMETHYLSILYL)ETHOXYME
Load more

Recommended publications
  • Commission Implementing Regulation (EU)
    21.3.2013 EN Official Journal of the European Union L 80/1 II (Non-legislative acts) REGULATIONS COMMISSION IMPLEMENTING REGULATION (EU) No 230/2013 of 14 March 2013 on the withdrawal from the market of certain feed additives belonging to the group of flavouring and appetising substances (Text with EEA relevance) THE EUROPEAN COMMISSION, submitted before that deadline for the only animal category for which those feed additives had been auth­ orised pursuant to Directive 70/524/EEC. Having regard to the Treaty on the Functioning of the European Union, (4) For transparency purposes, feed additives for which no applications for authorisation were submitted within the Having regard to Regulation (EC) No 1831/2003 of the period specified in Article 10(2) of Regulation (EC) No European Parliament and of the Council of 22 September 1831/2003 were listed in a separate part of the 2003 on additives for use in animal nutrition ( 1 ), and in Community Register of Feed Additives. particular Article 10(5) thereof, (5) Those feed additives should therefore be withdrawn from Whereas: the market as far as their use as flavouring and appetising substances is concerned, except for animal species and categories of animal species for which applications for (1) Regulation (EC) No 1831/2003 provides for the auth­ authorisation have been submitted. This measure does orisation of additives for use in animal nutrition and not interfere with the use of some of the abovemen­ for the grounds and procedures for granting such auth­ tioned additives according to other animal species or orisation. Article 10 of that Regulation provides for the categories of animal species or to other functional re-evaluation of additives authorised pursuant to Council groups for which they may be allowed.
    [Show full text]
  • Test Items for Licensing Examination Krok 1 PHARMACY
    MINISTRY OF PUBLIC HEALTH OF UKRAINE Department of human resources policy, education and science Testing Board Student ID Last name Variant ________________ Test items for licensing examination Krok 1 PHARMACY (російськомовний варіант) General Instruction Every one of these numbered questions or unfinished statements in this chapter corresponds to answers or statements endings. Choose the answer (finished statements) that fits best and fill in the circle with the corresponding Latin letter on the answer sheet. Authors of items: Abramov A.V., Aleksandrova K.V., Andronov D.Yu., Bilyk O.V., Blinder O.O., Bobyr V.V., Bobrovska O.A., Bohatyriova O.V., Bodnarchuk O.V., Boieva S.S., Bolokhovska T.O., Bondarenko Yu.I., Bratenko M.K., Buchko O.V., Cherneha H.V., Davydova N.V., Deriuhina L.I., Didenko N.O., Dmytriv A.M., Doroshkevych I.O., Dutka N.M., Dynnyk K.V., Filipova L.O., Havryliuk I.M., Herhel T.M., Hlushkova O.M., Hozhdzinsky S.M., Hrekova T.A., Hrechana O.V., Hruzevsky O.A., Hudyvok Ya.S., Hurmak I.S., Ivanets L.M., Ivanov Ye.I., Kartashova T.V., Kava T.V., Kazakova V.V., Kazmirchuk H.V., Kernychna I.Z., Khlus K.M., Khmelnykova L.I., Klebansky Ye.O., Klopotsky H.A., Klymniuk S.I., Kobylinska L.I., Koldunov V.V., Kolesnyk V.P., Kolesnikova T.O., Komlevoy O.M., Kononenko N.M., Kornijevsky Yu.Y., Kremenska L.V., Krushynska T.Yu., Kryzhanovska A.V., Kryshtal M.V., Kukurychkin Ye.R., Kuznietsova N.L., Kuzmina A.V., Lisnycha A.M., Lychko V.H., Makats Ye.F., Maly V.V., Matvijenko A.H., Menchuk K.M., Minarchenko V.M., Mikheiev A.O., Mishchenko
    [Show full text]
  • Effect of Rutin on Gentamicin-Induced Ototoxicity in Rats: a Biochemical and Histopathological Examination
    ORIGINAL ARTICLE ENT UPDATES 11(1):8-13 DOI: 10.5152/entupdates.2021.887158 Effect of Rutin on Gentamicin-Induced Ototoxicity in Rats: A Biochemical and Histopathological Examination Abstract Objective: Gentamicin is a broad-spectrum aminoglycoside antibiotic administered parenterally for moderate to severe gram-negative infections. Ototoxicity is an im- portant side effect that limits gentamicin use. The aim of this study is to investigate the effect of rutin on gentamicin-induced ototoxicity in rats biochemically and histo- pathologically. Methods: Distilled water was administered by oral gavage to healthy controls (HG) and cobalt administered group (GC). 50 mg/kg rutin was administered by oral gavage to rutin + gentamicin (RGG) group. After one hour, 100 mg/kg gentamicin was injected intraperitoneally (i.p) to the RGG and GC animal groups. This procedure was repeated once a day for 14 days. Results: Malondialdehyde (MDA), nuclear factor-κB(NF-κB), tumor necrosis factor alpha (TNF-α) and interleukin-1 beta(IL-1β) levels in the cochlear nerve tissue of gen- tamicin-treated animals were significantly higher compared to healthy controls and rutin + gentamicin treated rats. On the other hand, the amount of total Glutathione (tGSH) was significantly lower compared to the control and rutin group. Histopatho- logical examination revealed degenerated myelinated nerve fibers in the gentamicin group and Schwann cell nuclei were generally not seen. There was a high accumula- tion of collagen fiber in the tissue and dilated blood capillaries. In the rutin group, my- elinated nerve fibers mostly exhibited normal morphology, Schwann cell nuclei were İsmail Salcan1 evident and the vessels were normal.
    [Show full text]
  • Aldrich Raman
    Aldrich Raman Library Listing – 14,033 spectra This library represents the most comprehensive collection of FT-Raman spectral references available. It contains many common chemicals found in the Aldrich Handbook of Fine Chemicals. To create the Aldrich Raman Condensed Phase Library, 14,033 compounds found in the Aldrich Collection of FT-IR Spectra Edition II Library were excited with an Nd:YVO4 laser (1064 nm) using laser powers between 400 - 600 mW, measured at the sample. A Thermo FT-Raman spectrometer (with a Ge detector) was used to collect the Raman spectra. The spectra were saved in Raman Shift format. Aldrich Raman Index Compound Name Index Compound Name 4803 ((1R)-(ENDO,ANTI))-(+)-3- 4246 (+)-3-ISOPROPYL-7A- BROMOCAMPHOR-8- SULFONIC METHYLTETRAHYDRO- ACID, AMMONIUM SALT PYRROLO(2,1-B)OXAZOL-5(6H)- 2207 ((1R)-ENDO)-(+)-3- ONE, BROMOCAMPHOR, 98% 12568 (+)-4-CHOLESTEN-3-ONE, 98% 4804 ((1S)-(ENDO,ANTI))-(-)-3- 3774 (+)-5,6-O-CYCLOHEXYLIDENE-L- BROMOCAMPHOR-8- SULFONIC ASCORBIC ACID, 98% ACID, AMMONIUM SALT 11632 (+)-5-BROMO-2'-DEOXYURIDINE, 2208 ((1S)-ENDO)-(-)-3- 97% BROMOCAMPHOR, 98% 11634 (+)-5-FLUORODEOXYURIDINE, 769 ((1S)-ENDO)-(-)-BORNEOL, 99% 98+% 13454 ((2S,3S)-(+)- 11633 (+)-5-IODO-2'-DEOXYURIDINE, 98% BIS(DIPHENYLPHOSPHINO)- 4228 (+)-6-AMINOPENICILLANIC ACID, BUTANE)(N3-ALLYL)PD(II) CL04, 96% 97 8167 (+)-6-METHOXY-ALPHA-METHYL- 10297 ((3- 2- NAPHTHALENEACETIC ACID, DIMETHYLAMINO)PROPYL)TRIPH 98% ENYL- PHOSPHONIUM BROMIDE, 12586 (+)-ANDROSTA-1,4-DIENE-3,17- 99% DIONE, 98% 13458 ((R)-(+)-2,2'- 963 (+)-ARABINOGALACTAN BIS(DIPHENYLPHOSPHINO)-1,1'-
    [Show full text]
  • An Overview on “Stages of Anesthesia and Some Novel General Anesthetics Drug”
    Rohit Jaysing Bhor. et al. /Asian Journal of Research in Chemistry and Pharmaceutical Sciences. 5(4), 2017, 132-140. Review Article ISSN: 2349 – 7106 Asian Journal of Research in Chemistry and Pharmaceutical Sciences Journal home page: www.ajrcps.com AN OVERVIEW ON “STAGES OF ANESTHESIA AND SOME NOVEL GENERAL ANESTHETICS DRUG” Rohit Jaysing Bhor *1 , Bhadange Shubhangi 1, C. J. Bhangale 1 1* Department of Pharmaceutical Chemistry, PRES’s College of Pharmacy Chincholi, Tal-Sinner, Dist-Nasik, Maharashtra, India. ABSTRACT Anesthesia is a painless performance of medical producers. There are both major and minor risks of anesthesia. Anesthesia is a state of temporary induced loss of sensation or awareness. It gives analgesia i.e. relief from pain or prevention of pain and paralysis. General anaesthesia is a medically induced state of unconsciousness. It gives loss of protective reflux. It is carried out to allow medical procedures or medical surgery. It can be classified into 3 types like Intravenous Anesthetics Drug; Miscellaneous Drug; and Inhalational anesthetic Drug. Sodium thiopental is an ultra-short-acting barbiturate and has been used commonly in the induction phase of anesthesia. Methohexital is an example of barbiturates derivatives. It is classified as short-acting, and has a rapid onset of action. KEYWORDS Anesthesia, Sodium thiopental, Methohexital and Propofol. Author for Correspondence: INTRODUCTON Anesthesia is a state of temporary induced loss of sensation or awareness. It gives analgesia i.e. relief 1 Rohit Jaysing Bhor, from pain or prevention of pain and paralysis . A patient under the effects of anesthetic drug is known Department of Pharmaceutical Chemistry, as anesthetized.
    [Show full text]
  • Reactions of Some 1-Arylpiperazines and 1-Aryl-4-(2-Hydroxy-3
    Reactions of Some l-Arylpiperazines and -Aryl-4- (2-Hydroxy-3-Methoxypropyl) Piperazines By HILDA HOWELL A DISSERTATION PRESENTED TO THE GRADUATE COUNQL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY UNIVERSITY OF FLORIDA August, 1961 5 ACKNOWLEDGMENTS The author would like to thank Parke, Davis and Company who provided a graduate fellowship during part of this work. The able assistance of the faculty, staff, and fellow graduate students of the Chemistry Department has made this research quite pleasant. Thanks are also due to Miss Joan Merritt, Mrs. Marie Eckart, Mr. T. W. Brooks, and Mr. Ralph Damico for their help with the typing, drawings, and proofreading of this report. The special consideration of Mr. P. L. Bhatia who shared this laboratory is appreciated. Special recognition is offered to D». C. B. Smith, Commdr. N. L. Smith, Dr. W. M. Jones, and Dr. G. B. Butler, each of whom from his own ability and opportunity has been of inestimable help. The moral support of her parents, family, and friends has significantly contributed to the success of this graduate program. She is deeply indebted to Dr* C. B. Pollard for his inspiration and direction !n the early part of this work and to her graduate ccKnmittee for their friendship demonstrated particularly since his death. She is especially indebted to Dr. Harry H. Slsler for the under- standing way in which he has directed the completion of this research. His friexidship and encouragement have made graduate work an enjoyable experience. ^ TABLE OF CONTENTS Page ACKNOWLEDGMENTS.
    [Show full text]
  • 56 Subpart F—Flavoring Agents and Related Substances
    § 172.510 21 CFR Ch. I (4–1–12 Edition) needed to produce its intended effect (a) They are used in the minimum but not in excess of 13 parts per million quantity required to produce their in- calculated as anhydrous sodium ferro- tended physical or technical effect and cyanide. in accordance with all the principles of [42 FR 14491, Mar. 15, 1977, as amended at 58 good manufacturing practice. FR 17098, Apr. 1, 1993] (b) In the appropriate forms (plant parts, fluid and solid extracts, con- Subpart F—Flavoring Agents and centrates, absolutes, oils, gums, bal- Related Substances sams, resins, oleoresins, waxes, and dis- tillates) they consist of one or more of § 172.510 Natural flavoring substances the following, used alone or in com- and natural substances used in con- bination with flavoring substances and junction with flavors. adjuvants generally recognized as safe Natural flavoring substances and in food, previously sanctioned for such natural adjuvants may be safely used use, or regulated in any section of this in food in accordance with the fol- part. lowing conditions. Common name Scientific name Limitations Aloe ................................................................ Aloe perryi Baker, A. barbadensis Mill., A. ferox Mill., and hybrids of this sp. with A. africana Mill. and A. spicata Baker. Althea root and flowers .................................. Althea officinalis L. Amyris (West Indian sandalwood) ................. Amyris balsamifera L. Angola weed .................................................. Roccella fuciformis
    [Show full text]
  • Air Pollution Control General Definitions Regulation, State Of
    STATE RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF ENVIRONMENTAL MANAGEMENT OFFICE OF AIR RESOURCES AIR POLLUTION CONTROL GENERAL DEFINITIONS REGULATION Applicability Unless otherwise expressly defined by an individual Air Pollution Control Regulation, the terms, definitions and unit of measure abbreviations contained herein shall be generally applicable to all Rhode Island Air Pollution Control Regulations adopted or amended at the same time as or after the adoption of these definitions. Definitions “Act” or “Clean Air Act” or “CAA” means the Federal Clean Air Act, as amended 42 U.S.C. 7401, et seq. “Actual heat input” means the gross heat release potential based upon the actual BTU content of the fossil fuel being burned and the rate at which it is burned. “Administrator” means the Administrator of the United States Environmental Protection Agency or the Administrator's duly authorized representative. “Aerodynamic downwash” means the rapid descent of a plume to ground level with little dilution and dispersion due to alteration of background air flow characteristics caused by the presence of buildings or other obstacles in the vicinity of the emission point. “Air contaminant” means soot, cinders, ashes, any dust, fumes, gas, mist, smoke, vapor, odor, toxic or radioactive material, particulate matter, or any combination of these. “Air pollution” means the presence in the outdoor atmosphere of one or more air contaminants in sufficient quantities which, either alone or in connection with other emissions, by reason of their concentration and duration, may be injurious to human, plant or animal life, or cause damage to property or which unreasonably interferes with the enjoyment of life and property.
    [Show full text]
  • RIFM Fragrance Ingredient Safety Assessment, Menthyl Isovalerate CAS Registry Number 16409-46-4
    Food and Chemical Toxicology 110 (2017) S486eS495 Contents lists available at ScienceDirect Food and Chemical Toxicology journal homepage: www.elsevier.com/locate/foodchemtox Short review RIFM fragrance ingredient safety assessment, menthyl isovalerate CAS Registry Number 16409-46-4 * A.M. Api a, , D. Belsito b, D. Botelho a, D. Browne a, M. Bruze c, G.A. Burton Jr. d, J. Buschmann e, M.L. Dagli f, M. Date a, W. Dekant g, C. Deodhar a, M. Francis a, A.D. Fryer h, K. Joshi a,S.LaCavaa, A. Lapczynski a, D.C. Liebler i, D. O'Brien a, R. Parakhia a,A.Patela, T.M. Penning j, G. Ritacco a, J. Romine a, D. Salvito a, T.W. Schultz k, I.G. Sipes l, Y. Thakkar a, E.H. Theophilus a, A.K. Tiethof a, Y. Tokura m, S. Tsang a, J. Wahler a a Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA b Member RIFM Expert Panel, Columbia University Medical Center, Department of Dermatology, 161 Fort Washington Ave., New York, NY 10032, USA c Member RIFM Expert Panel, Malmo University Hospital, Department of Occupational & Environmental Dermatology, Sodra Forstadsgatan 101, Entrance 47, Malmo SE-20502, Sweden d Member RIFM Expert Panel, School of Natural Resources & Environment, University of Michigan, Dana Building G110, 440 Church St., Ann Arbor, MI 58109, USA e Member RIFM Expert Panel, Fraunhofer Institute for Toxicology and Experimental Medicine, Nikolai-Fuchs-Strasse 1, 30625 Hannover, Germany f Member RIFM Expert Panel, University of Sao Paulo, School of Veterinary Medicine and Animal Science, Department of Pathology, Av.
    [Show full text]
  • Production of Malonic Acid Through the Fermentation of Glucose
    University of Pennsylvania ScholarlyCommons Department of Chemical & Biomolecular Senior Design Reports (CBE) Engineering 4-20-2018 Production of Malonic Acid through the Fermentation of Glucose Emily P. Peters University of Pennsylvania, [email protected] Gabrielle J. Schlakman University of Pennsylvania, [email protected] Elise N. Yang University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/cbe_sdr Part of the Biochemical and Biomolecular Engineering Commons Peters, Emily P.; Schlakman, Gabrielle J.; and Yang, Elise N., "Production of Malonic Acid through the Fermentation of Glucose" (2018). Senior Design Reports (CBE). 107. https://repository.upenn.edu/cbe_sdr/107 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/cbe_sdr/107 For more information, please contact [email protected]. Production of Malonic Acid through the Fermentation of Glucose Abstract The overall process to produce malonic acid has not drastically changed in the past 50 years. The current process is damaging to the environment and costly, requiring high market prices. Lygos, Inc., a lab in Berkeley, California, has published a patent describing a way to produce malonic acid through the biological fermentation of genetically modified easty cells. This proposed technology is appealing as it is both better for the environment and economically friendly. For the process discussed in this report, genetically modified Pichia Kudriavzevii yeast cells will be purchased from the Lygos lab along with the negotiation of exclusive licensing rights to the technology. The cells will be grown in fermentation vessels, while being constantly fed oxygen, glucose and fermentation media. The cells will excrete malonic acid in the 101 hour fermentation process.
    [Show full text]
  • Preparation of Amine Alanes
    Europaisches Patentamt J European Patent Office 00 Publication number: 0 273 229 Office europeen des brevets A2 EUROPEAN PATENT APPLICATION © Application number: 87117901.6 © mt. ci.<: C01B 6/06 , C07C 87/00 © Date of filing: 03.12.87 © Priority: 22.12.86 US 945286 © Applicant: ETHYL CORPORATION Ethyl Tower 451 Florida Boulevard ® Date of publication of application: Baton Rouge Louisiana 70801 (US) 06.07.88 Bulletin 88/27 @ Inventor: Marlett, Everett Michael ® Designated Contracting States: 9355 Greenbriar Drive AT BE CH DE ES FR GB IT LI LU NL SE Baton Rouge Louisiana 7081 5(US) 0 Representative: Sandmair, Kurt, Dr. Patentanwalte Schwabe, Sandmair, Marx Stuntzstrasse 16 D-8000 MUnchen 80(DE) © Preparation of amine alanes. © Process for the preparation of an amine alane, said process comprising reacting: (a) an alkali metal aluminum tetrahydride having the formula MAIH4, wherein M is an alkali metal selected from the class consisting of lithium, sodium and potassium, (b) a hydrogen halide, and (c) a complexing tertiary amine. In this process, NaAlhU, HCI, and (C2H5)3N are preferred reactants. CM CM a. LU Xerox Copy Centre 0 273 229 PREPARATION OF AM1NE ALANES The invention pertains to the formation of amine alanes AIH3«NR3. These materials are useful as chemical intermediates. For example, they can be reacted with a silicon halide such as SiCU or SiF4 to produce silane. Reference is made to U.S. 4,474,743. It pertains to production of silane and aluminum fluoride from silicon tetrafluoride and amine alanes. Reference is also made to U.S. 4,006,095. It teaches, inter alia, that SiCU reacts with a toluene solution of AIH3 containing dimethyl ether or a stabilizing amine.
    [Show full text]
  • WO 2013/089962 Al 20 June 2013 (20.06.2013) W P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/089962 Al 20 June 2013 (20.06.2013) W P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every B01J 31/04 (2006.01) B01J 31/18 (2006.01) kind of national protection available): AE, AG, AL, AM, B01J 31/14 (2006.01) B01J 31/22 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) Number: International Application DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US20 12/065285 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 15 November 2012 (15.1 1.2012) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (25) Filing Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, (26) Publication Language: English TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 13/323,328 12 December 201 1 (12. 12.201 1) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant (for all designated States except US): CHEV¬ GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, RON PHILLIPS CHEMICAL COMPANY LP UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, [US/US]; 10001 Six Pines Drive, The Woodlands, Texas TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 77380 (US).
    [Show full text]